Heidegger I - Search Results

1

New antiangiogenic strategies beyond inhibition of vascular endothelial growth factor with special focus on axon guidance molecules.

Pircher A, Wellbrock J, Fiedler W, Heidegger I, Gunsilius E, Hilbe W. Pircher A, et al. Among authors: heidegger i. Oncology. 2014;86(1):46-52. doi: 10.1159/000356871. Epub 2014 Jan 3. Oncology. 2014. PMID: 24401553 Review.

2

Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach?

Marra G, Ploussard G, Futterer J, Valerio M; EAU-YAU Prostate Cancer Working Party. Marra G, et al. World J Urol. 2019 Feb;37(2):277-287. doi: 10.1007/s00345-018-02622-5. Epub 2019 Jan 4. World J Urol. 2019. PMID: 30610359 Review.

3

Targeting the insulin-like growth factor network in cancer therapy.

Heidegger I, Pircher A, Klocker H, Massoner P. Heidegger I, et al. Cancer Biol Ther. 2011 Apr 15;11(8):701-7. doi: 10.4161/cbt.11.8.14689. Epub 2011 Apr 15. Cancer Biol Ther. 2011. PMID: 21311212 Free article. Review.

4

Biomarkers in tumor angiogenesis and anti-angiogenic therapy.

Pircher A, Hilbe W, Heidegger I, Drevs J, Tichelli A, Medinger M. Pircher A, et al. Among authors: heidegger i. Int J Mol Sci. 2011;12(10):7077-99. doi: 10.3390/ijms12107077. Epub 2011 Oct 21. Int J Mol Sci. 2011. PMID: 22072937 Free PMC article. Review.

5

Favorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs).

Pircher A, Fiegl M, Untergasser G, Heidegger I, Medinger M, Kern J, Hilbe W. Pircher A, et al. Among authors: heidegger i. Lung Cancer. 2013 Aug;81(2):252-8. doi: 10.1016/j.lungcan.2013.04.014. Epub 2013 May 10. Lung Cancer. 2013. PMID: 23664449

6

Novel therapeutic approaches for the treatment of castration-resistant prostate cancer.

Heidegger I, Massoner P, Eder IE, Pircher A, Pichler R, Aigner F, Bektic J, Horninger W, Klocker H. Heidegger I, et al. J Steroid Biochem Mol Biol. 2013 Nov;138:248-56. doi: 10.1016/j.jsbmb.2013.06.002. Epub 2013 Jun 20. J Steroid Biochem Mol Biol. 2013. PMID: 23792785 Free PMC article. Review.

7

Latent hypothyreosis as a clinical biomarker for therapy response under abiraterone acetate therapy.

Heidegger I, Nagele U, Pircher A, Pichler R, Horninger W, Bektic J. Heidegger I, et al. Anticancer Res. 2014 Jan;34(1):307-11. Anticancer Res. 2014. PMID: 24403479

8

Ulcerative skin metastases of primary lung cancer.

Pircher A, Gastl G, Heidegger I. Pircher A, et al. Among authors: heidegger i. Jpn J Clin Oncol. 2015 Jan;45(1):135. doi: 10.1093/jjco/hyu213. Jpn J Clin Oncol. 2015. PMID: 25542961 No abstract available.

9

High risk of under-grading and -staging in prostate cancer patients eligible for active surveillance.

Heidegger I, Skradski V, Steiner E, Klocker H, Pichler R, Pircher A, Horninger W, Bektic J. Heidegger I, et al. PLoS One. 2015 Feb 6;10(2):e0115537. doi: 10.1371/journal.pone.0115537. eCollection 2015. PLoS One. 2015. PMID: 25658878 Free PMC article. Clinical Trial.

10

Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies.

Pircher A, Jöhrer K, Kocher F, Steiner N, Graziadei I, Heidegger I, Pichler R, Leonhartsberger N, Kremser C, Kern J, Untergasser G, Gunsilius E, Hilbe W. Pircher A, et al. Among authors: heidegger i. Oncotarget. 2016 Apr 12;7(15):20109-23. doi: 10.18632/oncotarget.7915. Oncotarget. 2016. PMID: 26956051 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters